Bioensaio/métodos; Testes de Carcinogenicidade; Carcinógenos/toxicidade; Animais; Carcinógenos/análise; Dano ao DNA; Bases de Dados Factuais; Avaliação Pré-Clínica de Medicamentos; Humanos; Internet; Camundongos; Neoplasias/induzido quimicamente; Ratos

Ames mutagenicity assay; BCP; CAR; CPDB; Cancer bioassay; Carcinogenic Potency Database; DNA; EAFUS; EU; European Union; Everything Added to Food in the United States; FDA; Genotoxicity; HSDB; Hazardous Substances Data Bank; Human relevance; IARC; IPCS; International Agency for Research on Cancer; International Programme on Chemical Safety; MTD; Maximum Tolerated Dose; Mode of action; NCI; NTP; National Cancer Institute; National Toxicology Program; Non-genotoxic carcinogens; OECD; OSTP; Organisation for Economic Co-operation and Development; PPARα; QSAR; REACH; Registration, Evaluation, Authorisation and Restriction of Chemical Substances; TD50; TSCA; Toxic Substances Control Act; U.S. Office of Science and Technology Policy; USEPA; United States Environmental Protection Agency; United States Food and Drug Administration; constitutive androstane receptor; deoxyribonucleic acid; median toxic dose value; o-benzyl-p-chlorophenol; peroxisome proliferator-activated receptor alpha; quantitative structure­activity